Every Cure Taps OpenEvidence to Advance Noncommercial Drug Repurposing

Every Cure announced a partnership with OpenEvidence on November 16, 2026, to advance new uses for existing medicines where commercial incentives are lacking, linking AI-supported drug evaluation with specialist input, clinical-trial recruitment and evidence distribution to physicians. Every Cure estimates that roughly 18,000 diseases are recognized but only about 4,000 have approved treatments, and that more than 300 million people globally have a disease with no FDA-approved treatment. Those…

This article has been indexed from Unite.AI